KR101788340B1 - 미처리된 및 부분적으로 처리된 신경독 타입 ａ를 결정하기 위한 시스템 - Google Patents

미처리된 및 부분적으로 처리된 신경독 타입 ａ를 결정하기 위한 시스템 Download PDF

Info

Publication number
KR101788340B1
KR101788340B1 KR1020127012793A KR20127012793A KR101788340B1 KR 101788340 B1 KR101788340 B1 KR 101788340B1 KR 1020127012793 A KR1020127012793 A KR 1020127012793A KR 20127012793 A KR20127012793 A KR 20127012793A KR 101788340 B1 KR101788340 B1 KR 101788340B1
Authority
KR
South Korea
Prior art keywords
bont
polypeptide
neurotoxin
untreated
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020127012793A
Other languages
English (en)
Korean (ko)
Other versions
KR20120102639A (ko
Inventor
해롤드 브이. 테일러
칼-하인츠 아이젤레
코르넬리아 브뢴
Original Assignee
메르츠 파마 게엠베하 운트 코. 카가아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41466928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101788340(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 메르츠 파마 게엠베하 운트 코. 카가아 filed Critical 메르츠 파마 게엠베하 운트 코. 카가아
Publication of KR20120102639A publication Critical patent/KR20120102639A/ko
Application granted granted Critical
Publication of KR101788340B1 publication Critical patent/KR101788340B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96402—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals
    • G01N2333/96405—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general
    • G01N2333/96408—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general with EC number
    • G01N2333/96419—Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
KR1020127012793A 2009-10-21 2010-10-18 미처리된 및 부분적으로 처리된 신경독 타입 ａ를 결정하기 위한 시스템 Expired - Fee Related KR101788340B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US27945309P 2009-10-21 2009-10-21
EP09173612 2009-10-21
EP09173612.4 2009-10-21
US61/279,453 2009-10-21
PCT/EP2010/065618 WO2011048044A1 (en) 2009-10-21 2010-10-18 System for determining unprocessed and partially processed neurotoxin type a

Publications (2)

Publication Number Publication Date
KR20120102639A KR20120102639A (ko) 2012-09-18
KR101788340B1 true KR101788340B1 (ko) 2017-10-19

Family

ID=41466928

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127012793A Expired - Fee Related KR101788340B1 (ko) 2009-10-21 2010-10-18 미처리된 및 부분적으로 처리된 신경독 타입 ａ를 결정하기 위한 시스템

Country Status (15)

Country Link
US (2) US8841080B2 (enExample)
EP (1) EP2491384B1 (enExample)
JP (1) JP5709877B2 (enExample)
KR (1) KR101788340B1 (enExample)
CN (1) CN102597769B (enExample)
AU (1) AU2010309932B2 (enExample)
BR (1) BR112012009436A2 (enExample)
CA (1) CA2773478C (enExample)
ES (1) ES2449303T3 (enExample)
IL (1) IL218455A (enExample)
IN (1) IN2012DN01954A (enExample)
MX (1) MX2012004454A (enExample)
PT (1) PT2491384E (enExample)
RU (1) RU2545825C9 (enExample)
WO (1) WO2011048044A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1786459B1 (en) * 2004-07-26 2014-02-12 Merz Pharma GmbH & Co. KGaA Therapeutic composition whit a botulinum neurotoxin
RU2549463C1 (ru) * 2013-12-03 2015-04-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ определения ботулинического нейротоксина типа а на основе иммунодетекции, сопряженной с полимеразной цепной реакцией
GB201407525D0 (en) * 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002501033A (ja) 1998-01-26 2002-01-15 ユニバーシティー オブ マサチューセッツ Ａ型ボツリヌス菌の生物学的活性赤血球凝集素とその使用法
JP2004512004A (ja) 1999-05-12 2004-04-22 ユナイテッド　ステイツ　アーミー　メディカル　リサーチ　アンド　マテリエル　シーエムディー ボツリヌス神経毒に対する組換えワクチン
US20060177881A1 (en) 1998-12-17 2006-08-10 Sina Bavari Antibodies against type A botulinum neurotoxin
WO2008157374A1 (en) 2007-06-13 2008-12-24 The United States Of America, As Represented By The Secretrary Of Agriculture High-affinity monoclonal antibodies for botulinum toxin type a

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080171347A1 (en) * 2003-04-11 2008-07-17 Atassi M Zouhair Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
CN100575363C (zh) * 2007-03-07 2009-12-30 中国人民解放军军事医学科学院微生物流行病研究所 人源抗a型肉毒神经毒素基因工程抗体及其制备方法与用途
BRPI1008885B1 (pt) * 2009-02-19 2021-09-28 Merz Pharma Gmbh & Co. Kgaa Método para obter uma solução purificada de polipeptídeos de neurotoxina processados e composição
CN101503472B (zh) * 2009-03-17 2011-08-10 中国人民解放军军事医学科学院生物工程研究所 抗a型肉毒毒素的人源性中和抗体及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002501033A (ja) 1998-01-26 2002-01-15 ユニバーシティー オブ マサチューセッツ Ａ型ボツリヌス菌の生物学的活性赤血球凝集素とその使用法
US20060177881A1 (en) 1998-12-17 2006-08-10 Sina Bavari Antibodies against type A botulinum neurotoxin
JP2004512004A (ja) 1999-05-12 2004-04-22 ユナイテッド　ステイツ　アーミー　メディカル　リサーチ　アンド　マテリエル　シーエムディー ボツリヌス神経毒に対する組換えワクチン
WO2008157374A1 (en) 2007-06-13 2008-12-24 The United States Of America, As Represented By The Secretrary Of Agriculture High-affinity monoclonal antibodies for botulinum toxin type a

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal. of the Food Hygienics Soci ety of Japan, February 25, 2007, Vol. 48, No. 1, p.19-26

Also Published As

Publication number Publication date
CA2773478A1 (en) 2011-04-28
US9213026B2 (en) 2015-12-15
EP2491384A1 (en) 2012-08-29
RU2545825C2 (ru) 2015-04-10
EP2491384B1 (en) 2013-12-04
BR112012009436A2 (pt) 2017-02-21
IL218455A0 (en) 2012-04-30
JP2013508701A (ja) 2013-03-07
PT2491384E (pt) 2014-02-21
US20120214182A1 (en) 2012-08-23
RU2012120572A (ru) 2013-11-27
CN102597769B (zh) 2014-11-05
RU2545825C9 (ru) 2015-06-20
AU2010309932A1 (en) 2012-04-05
MX2012004454A (es) 2012-05-22
AU2010309932B2 (en) 2015-04-16
US20140349322A1 (en) 2014-11-27
KR20120102639A (ko) 2012-09-18
ES2449303T3 (es) 2014-03-19
IL218455A (en) 2015-10-29
US8841080B2 (en) 2014-09-23
JP5709877B2 (ja) 2015-04-30
CN102597769A (zh) 2012-07-18
HK1173493A1 (zh) 2013-05-16
WO2011048044A1 (en) 2011-04-28
CA2773478C (en) 2018-07-17
IN2012DN01954A (enExample) 2015-08-21

Similar Documents

Publication Publication Date Title
KR101806567B1 (ko) 매우 순수한 신경독을 제조하기 위한 수단 및 방법
JP5689113B2 (ja) ニューロトキシンポリペプチドの量の測定とその触媒及びタンパク質分解活性の測定のための手段及び方法
US9213026B2 (en) System for determining unprocessed and partially processed neurotoxin type A
HK1173493B (en) System for determining unprocessed and partially processed neurotoxin a polypeptide
RU2807994C2 (ru) Анализ расщепления клеточного vamp
HK1165436A (en) Means and methods for manufacturing highly pure neurotoxin
HK1165436B (en) Means and methods for manufacturing highly pure neurotoxin

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20201005

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20211005

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20221005

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241014

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241014

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241014